Citadel Advisors’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-261,200
| Closed | -$5.27M | – | 7661 |
|
|
2021
Q3 | $5.27M | Sell |
261,200
-72,328
| -22% | -$1.46M | ﹤0.01% | 2002 |
|
|
2021
Q2 | $12.4M | Sell |
333,528
-154,975
| -32% | -$5.78M | ﹤0.01% | 1274 |
|
|
2021
Q1 | $12.5M | Sell |
488,503
-1,415,275
| -74% | -$36.2M | ﹤0.01% | 1275 |
|
|
2020
Q4 | $41.9M | Buy |
1,903,778
+198,906
| +12% | +$4.38M | 0.01% | 507 |
|
|
2020
Q3 | $30.7M | Buy |
1,704,872
+723,720
| +74% | +$13M | 0.01% | 568 |
|
|
2020
Q2 | $24.9M | Sell |
981,152
-1,045,646
| -52% | -$26.6M | 0.01% | 660 |
|
|
2020
Q1 | $37.2M | Sell |
2,026,798
-13,125
| -0.6% | -$241K | 0.02% | 430 |
|
|
2019
Q4 | $44.9M | Buy |
2,039,923
+108,455
| +6% | +$2.39M | 0.02% | 462 |
|
|
2019
Q3 | $27.7M | Sell |
1,931,468
-253,941
| -12% | -$3.65M | 0.01% | 656 |
|
|
2019
Q2 | $34.4M | Buy |
2,185,409
+163,799
| +8% | +$2.58M | 0.02% | 540 |
|
|
2019
Q1 | $29.6M | Buy |
2,021,610
+20,911
| +1% | +$306K | 0.01% | 573 |
|
|
2018
Q4 | $21.4M | Buy |
2,000,699
+50,504
| +3% | +$540K | 0.01% | 655 |
|
|
2018
Q3 | $29.8M | Buy |
1,950,195
+237,880
| +14% | +$3.63M | 0.01% | 593 |
|
|
2018
Q2 | $21M | Buy |
1,712,315
+1,541,574
| +903% | +$18.9M | 0.01% | 688 |
|
|
2018
Q1 | $1.63M | Buy |
+170,741
| New | +$1.63M | ﹤0.01% | 2076 |
|
|
2015
Q2 | – | Sell |
-10,183
| Closed | -$245K | – | 4250 |
|
|
2015
Q1 | $245K | Buy |
+10,183
| New | +$245K | ﹤0.01% | 3019 |
|